‹ All stocks
Drugs Made In America Acquisition Corp. Units
DMAAU · NASDAQ · Financial Services
$10.89
▼ $0.10 (-0.91%)
Day range
$10.89 – $10.98
Year range
$10.30 – $12.50
Open
$10.98
Previous close
$10.99
Market cap
$357.82M
Volume (24h)
—
Volume (52w)
—
Performance
7D
— 0.00%
1M
▲ 0.64%
3M
▲ 2.64%
6M
▲ 3.71%
1Y
▲ 4.21%
YTD
▲ 3.62%
3Y
▲ 9.78%
5Y
▲ 9.78%
All-time
▲ 9.78%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
32.9M
About Drugs Made In America Acquisition Corp. Units
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.52 | 0.08% |
JPM JPMorgan Chase & Co. |
$330.92 | -0.92% |
V Visa |
$359.82 | -0.11% |
MA Mastercard Incorporated |
$551.37 | 0.01% |
BAC Bank of America |
$53.63 | -0.49% |